| 名稱 | ERBB4 E452K （NRG1b Dependent）/BaF3 |
| 型號(hào) | CBP73258 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | ERBB4 E452K （NRG1b Dependent）/BaF3,母細(xì)胞：BaF3，凍存條件：90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- MYC診斷標(biāo)準(zhǔn)品
- 【產(chǎn)品推介】MSI標(biāo)準(zhǔn)品
- 能量平衡的重要靶點(diǎn)——CRF1R和CRF2R
- 分享：CIRCULATE-Japan，輔助治療的“升級(jí)”和“降級(jí)”
- Cell Rep：發(fā)現(xiàn)治療乳腺癌轉(zhuǎn)移的重要新靶標(biāo)！
- 是激活還是沉默？基因表達(dá)的新路徑
- 腫瘤免疫藥靶細(xì)胞模型系列——GITR
- 心衰治療靶點(diǎn)：BNP/NPR1
- CD27藥物細(xì)胞篩選模型
- 科學(xué)家有望利用對(duì)療法敏感性的癌細(xì)胞來(lái)清除耐藥性癌細(xì)胞
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73258ERBB4 E452K （NRG1b Dependent）/BaF3
- 詳細(xì)內(nèi)容
| CBP73258 | |
| I. Introduction | |
Cell Line Name： | ERBB4 E452K (NRG1b Dependent)/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+10ng/ml NRG1-beta1 |
Mycoplasma Status: | Negative |
| II.Background | |
Human HER4 kinase, also known as Erb-B4, Proto-Oncogene-Like Protein C-ErbB-4, and Tyrosine Kinase-Type Cell Surface Receptor HER4, GenBank Accession No. NM_005235, a.a. 708-993, with an N-terminal GST-tag, expressed in a Baculovirus infected Sf9 cell expression system. MW=59.5 kDa. | |
| III. Representative Data | |
1.ERBB4 E452K (NRG1b Dependent)/BaF3
| |
2. Anti-proliferation assay
Figure 2. Anti-proliferation assay of two reference compounds on the ERBB4 E452K (NRG1b Dependent)/BaF3 Stable Cell line. | |
會(huì)員_a.png)